Clinical Trial

Expanded Access to RGX-202

Temporarily Not Available
View on ClinicalTrials.gov →
Summary
Provide single patient expanded access to RGX-202 for eligible patients
Trial Details
NCT Number NCT07652606
Lead Sponsor REGENXBIO Inc.
Updated on ClinicalTrials.gov 2026-06-17